AVAI BIO, INC. (OTC:AVAI) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on February 12, 2026. The Technology company reported Q0 revenue of .
AVAI BIO, INC. (OTC:AVAI) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on February 12, 2026.
The Technology company reported Q0 revenue of .
AVAI BIO, INC.'s stock currently trades at $0.40 with a market capitalization of $43.5M.
Current market data
OTC · AVAI
$0.13
Unchanged: $0.00 · 0.00%
Live quote updated
Keep reading
sec_filing ·
sec_filing ·
